Renal and hepatobiliary dysfunction in chronic obstructive pulmonary disease

Current Opinion in Pulmonary Medicine

Volumn 20, Issue 2, 2014, Pages 186-193

  Mapel, Douglas ^a  

^a LOVELACE CLINIC FOUNDATION   (United States)

Author keywords

chronic obstructive pulmonary disease; epidemiology; hepatobiliary; renal

Indexed keywords

ANOXIA; BILIARY TRACT DISEASES; CHRONIC DISEASE; COMORBIDITY; CREATININE; DISEASE PROGRESSION; HUMANS; HYPERCAPNIA; KIDNEY DISEASES; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS;

EID: 84894066163     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0000000000000024     Document Type: Review

References (36)

1. Schneider KM, O'Donnell BE, Dean D. Prevalence of multiple chronic conditions in the United States' Medicare population. Health Qual Life Outcomes 2009;7:82.
2. Baty F, Putora PM, Isenring B, et al. Comorbidities and burden of COPD: a population based case-control study. PLoS One 2013;8:e63285. The largest and most comprehensive population-based analysis of comorbidities in COPD, based on all hospitalizations for COPD in Switzerland from 2002 through 2010.
3. Mapel DW, Marton JP. Prevalence of renal and hepatobiliary disease, laboratory abnormalities, and potentially toxic medication exposures among personswith COPD. Int J Chron Obstruct Pulm Dis 2013;8:127-134. A population-based case-control analysis with the unique features of prevalence by specific ICD-9 category, laboratory data, and utilization of medication that may contribute to renal or hepatic injury.
4. Mapel DW, Hurley JS, Frost FJ, et al. Healthcare utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization. Arch Intern Med 2000;160:2653-2658.
5. Nobili A, Marengoni A, Tettamanti M, et al. Association between clusters of diseases and polypharmacy in hospitalized elderly patients: results from the REPOSI study. Eur J Intern Med 2011;22:597-602.
6. García-Olmos L, Alberquilla A, Ayala V, et al. Comorbidity in patients with chronic obstructive pulmonary disease in family practice: a cross sectional study. BMC Fam Pract 2013;14:11. A comprehensive assessment of comorbidities based on 3124 COPD patients identified in a network of primary care offices based in Madrid, Spain.
7. Ekstrom MP, Jogreus C, Strom KE. Comorbidity and sex-related differences in mortality in oxygen-dependent chronic obstructive pulmonary disease. PLoS One 2012;7:e35806. Detailed prevalence of specific comorbidies by sex in a cohort with severe COPD.
8. Gjerde B, Bakke PS, Ueland T, et al. The prevalence of undiagnosed renal failure in a cohort of COPD patients in western Norway. Respir Med 2012;106:361-366. One of the few studies that includes a detailed analysis of risk factors.
9. Incalzi RA, Corsonello A, Pedone C, et al. Chronic renal failure: a neglected comorbidity of COPD. Chest 2010;137:831-837.
10. Chandra D, Stamm JA, Palevsky PM, et al. The relationship between pulmonary emphysema and kidney function in smokers. Chest 2012;142:655-662. The only study to include CT scan data in a large research cohort.
11. Singanayagam A, Schembri S, Chalmers JD. Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc 2013;10:81-89. A meta-analysis of 37 articles and 189 772 patients that includes details about specific comorbidities.
12. Terzano C, Conti V, Di Stefano F, et al. Comorbidity, hospitalization, and mortality in COPD: results from a longitudinal study. Lung 2010;188:321-329.
13. Kent BD, Eltayeb EE, Woodman A, et al. The impact of chronic obstructive pulmonary disease and smoking on mortality and kidney transplantation in end-stage kidney disease. Am J Nephrol 2012;36:287-295. Detailed examination of COPD among 769984 dialysis patients in the United States.
14. van Gestel YR, Chonchol M, Hoeks SE, et al. Association between chronic obstructive pulmonary disease and chronic kidney disease in vascular surgery patients. Nephrol Dial Transplant 2009;24:2763-2767.
15. Rodrigues AJ, Evora PR, Bassetto S, et al. Risk factors for acute renal failure after heart surgery. Rev Bras Cir Cardiovasc 2009;24:441-446.
16. Platts MM, Hammond JD, Stuart-Harris CH. A study of cor pulmonale in patients with chronic bronchitis. Q J Med 1960;29:559-574.
17. White RJ, Woodings DF. Impaired water handling in chronic obstructive airways disease. Br Med J 1971;2:561-563.
18. Farber MO, Roberts LR, Weinberger MH, et al. Abnormalities of sodium and H2O handling in chronic obstructive lung disease. Arch Intern Med 1982;142:1326-1330.
19. Stewart AG, Waterhouse JC, Billings CG, et al. Effects of angiotensin converting enzyme inhibition on sodium excretion in patients with hypoxaemic chronic obstructive pulmonary disease. Thorax 1994;49:995-998.
20. Howes TQ, Deane CR, Levin GE, et al. The effects of oxygen and dopamine on renal and aortic blood flow in chronic obstructive pulmonary disease with hypoxemia and hypercapnia. Am J Respir Crit Care Med 1995;151(2 Pt 1):378-383.
21. Palange P. Renal and hormonal abnormalities in chronic obstructive pulmonary disease (COPD). Thorax 1998;53:989-991.
22. Skwarski KM, Morrison D, Barratt A, et al. Effects of hypoxia on renal hormonal balance in normal subjects and in patients with COPD. Respir Med 1998;92:1331-1336.
23. Campbell EJ, Short DS. The cause of oedema in'corpulmonale'. Lancet 1960;1:1184-1186.
24. Sharkey RA, Mulloy EM, O'Neill SJ. The acute effects of oxygen and carbon dioxide on renal vascular resistance in patients with an acute exacerbation of COPD. Chest 1999;115:1588-1592.
25. Bratel T, Ljungman S, Runold M, Stenvinkel P. Renal function in hypoxaemic chronic obstructive pulmonary disease: effects of long-term oxygen treatment. Respir Med 2003;97:308-316.
26. Lima MR, Burdmann EA, Cipullo JP. Oxygen therapy improves renal function in patients with chronic obstructive pulmonary disease. Ren Fail 2005;27:373-379.
27. Hemlin M, Ljungman S, Carlson J, et al. The effects of hypoxia and hypercapnia on renal and heart function, haemodynamics and plasma hormone levels in stable COPD patients. Clinical Respir J 2007;1:80-90.
28. Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 2006;17:17-25.
29. Ahmed SB, Ronksley PE, Hemmelgarn BR, et al. Nocturnal hypoxia and loss of kidney function. PLoS One 2011;6:e19029.
30. Sharkey RA, Mulloy EM, Kilgallen IA, O'Neill SJ. Renal functional reserve in patients with severe chronic obstructive pulmonary disease. Thorax 1997;52:411-415.
31. Chen CY, Hsu TW, Mao SJ, et al. Abnormal renal resistive index in patients with mild-to-moderate chronic obstructive pulmonary disease. COPD 2013;10:216-225. Demonstrates that renal functional reserve is correlated with airway obstruction and systemic inflammation.
32. Sofia M, Maniscalco M, Celentano L, et al. Abnormalities of renal endothelin during acute exacerbation in chronic obstructive pulmonary disease. Pulm Pharmacol Ther 2001;14:321-327.
33. Casanova C, de Torres JP, Navarro J, et al. Microalbuminuria and hypoxemia in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;182:1004-1010.
34. John M, Hussain S, Prayle A, et al. Target renal damage: the microvascular associations of increased aortic stiffness in patients with COPD. Respir Res 2013;14:31. Correlations between aortic stiffness, microalbuminuria, and hypoxemia are described in COPD.
35. Lin PJ, Shaya FT, Scharf SM. Economic implications of comorbid conditions among Medicaid beneficiaries with COPD. Respir Med 2010;104:697-704.
36. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-2128. Describes the global burden of COPD relative to other diseases and their changes over the last 20 years.